Byens Kiropraktor Aps

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  13.0% 6.8% 13.3% 19.2% 19.3%  
Credit score (0-100)  19 35 16 6 6  
Credit rating  BB BBB BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 288 0 0 0  
Gross profit  0.0 22.1 -64.3 0.0 -6.5  
EBITDA  146 22.1 -64.3 -3.1 -6.5  
EBIT  74.3 22.1 -64.3 -3.1 -6.5  
Pre-tax profit (PTP)  74.1 22.1 -64.3 -3.1 -6.5  
Net earnings  74.1 22.1 -76.3 -3.1 -6.5  
Pre-tax profit without non-rec. items  74.1 22.1 -64.3 -3.1 -6.5  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  142 56.9 0.0 0.0 0.0  
Shareholders equity total  73.5 95.7 19.4 20.6 14.1  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  232 159 41.5 20.6 14.1  

Net Debt  -64.6 -102 -41.5 -12.2 -5.7  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 288 0 0 0  
Net sales growth  -100.0% 0.0% -100.0% 0.0% 0.0%  
Gross profit  0.0 22.1 -64.3 0.0 -6.5  
Gross profit growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -13.6 0.0 0.0 -3.1 0.0  
Balance sheet total (assets)  232 159 42 21 14  
Balance sheet change%  -5.2% -31.6% -73.8% -50.3% -31.5%  
Added value  159.3 22.1 -64.3 0.0 -6.5  
Added value %  0.0% 7.7% 0.0% 0.0% 0.0%  
Investments  -100 -85 -57 0 0  

Net sales trend  -1.0 0.0 -1.0 0.0 0.0  
EBIT trend  3.0 4.0 -1.0 -2.0 -3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 7.7% 0.0% 0.0% 0.0%  
EBIT %  0.0% 7.7% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 0.0% 100.0%  
Net Earnings %  0.0% 7.7% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 7.7% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 7.7% 0.0% 0.0% 0.0%  
ROA %  31.1% 11.3% -64.2% -10.1% -37.3%  
ROI %  166.0% 24.1% -111.7% -15.7% -37.3%  
ROE %  196.9% 26.2% -132.5% -15.7% -37.3%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  31.7% 60.3% 46.8% 100.0% 100.0%  
Relative indebtedness %  0.0% 21.9% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% -13.5% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -44.3% -460.0% 64.6% 386.9% 87.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.4 1.6 1.9 0.0 0.0  
Current Ratio  0.4 1.6 1.9 0.0 0.0  
Cash and cash equivalent  64.6 101.9 41.5 12.2 5.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 35.4% 0.0% 0.0% 0.0%  
Net working capital  -79.9 38.8 19.4 20.6 14.1  
Net working capital %  0.0% 13.5% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0